Page last updated: 2024-10-27

gemfibrozil and Staphylococcal Infections

gemfibrozil has been researched along with Staphylococcal Infections in 2 studies

Staphylococcal Infections: Infections with bacteria of the genus STAPHYLOCOCCUS.

Research Excerpts

ExcerptRelevanceReference
"Ciprofloxacin was predominantly (65%) distributed in the cytosol."1.32Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus. ( Carryn, S; Seral, C; Tulkens, PM; Van Bambeke, F, 2003)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's1 (50.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Zborovszky, EC1
Santana-Cabrera, L1
Ramírez Rodríguez, A1
Díaz Mendoza, C1
Seral, C1
Carryn, S1
Tulkens, PM1
Van Bambeke, F1

Other Studies

2 other studies available for gemfibrozil and Staphylococcal Infections

ArticleYear
[Plasmapheresis in the treatment of an acute pancreatitis due to hypertriglyceridemia].
    Medicina clinica, 2014, Mar-20, Volume: 142, Issue:6

    Topics: Anti-Bacterial Agents; Critical Care; Enterococcus faecalis; Gemfibrozil; Gram-Positive Bacterial In

2014
Influence of P-glycoprotein and MRP efflux pump inhibitors on the intracellular activity of azithromycin and ciprofloxacin in macrophages infected by Listeria monocytogenes or Staphylococcus aureus.
    The Journal of antimicrobial chemotherapy, 2003, Volume: 51, Issue:5

    Topics: Anti-Bacterial Agents; Anti-Infective Agents; ATP Binding Cassette Transporter, Subfamily B; ATP Bin

2003